Spontaneous Complete Regression of Testicular Germ Cell Tumor: A Case Report

2019 ◽  
Vol 152 (Supplement_1) ◽  
pp. S60-S60
Author(s):  
S Shawn Liu ◽  
Sara Avalos Hernandez ◽  
Valeria Dal Zotto ◽  
Guillermo Herrera

Abstract Testicular germ cell tumors (TGCTs) may spontaneously regress, making it a diagnostic challenge. We present here a case of 39-year-old African American male with constant abdominal pain radiating into the back. Computed tomography identified bulky retroperitoneal lymphadenopathy. There was no history of testicular trauma. Ultrasonography of right testicle revealed multiple microcalcifications, and a laboratory test indicated elevated beta-hCG and LDH. Patient underwent right orchiectomy, which revealed a grossly well-demarcated white oval lesion (3.1 cm). Histologic examination identified a fibrotic lesion in a background of atrophic parenchyma consistent with scar tissue. The specimen was completely submitted for microscopic evaluation, but neoplasia was not identified. A placental alkaline phosphatase (PLAP) immunohistochemical stain failed to reveal residual germ cell neoplasm in situ. Biopsy of retroperitoneal lymph node identified malignant neoplastic cells expressing PLAP, CD117, CD30, and cytokeratin AE1/AE3. The morphology and immunophenotype were consistent with metastatic germ cell tumor. Spontaneous regression of TGCT is defined as partial or complete tumor disappearance without any treatment. The clinical presentation could be nonspecific. Histologically, tumor regression is indicated by formation of fibrous scar, testicular atrophy, microcalcification, lymphoplasmacytic infiltration, and hemosiderin-phagocytosed macrophages, all of which were present in the current case. However, similar histological features could be identified in testicular ischemia or infraction. Therefore, the diagnosis of complete regression of TGCT is challenging and frequently relies on the present of extragonadal germ cell tumor. In the current case, we reported a spontaneous complete regression of TGCT, supported by a spectrum of histological features and metastasis to retroperitoneal lymph node. Spontaneous regression of TGCT is rare, with less than 150 cases reported in the literature. Since there is a lack of definitive histologic criteria to diagnose complete spontaneous regression of TGCT, when scarring is seen in the testis, additional clinical and imaging evaluation should be followed.

Urology ◽  
2012 ◽  
Vol 80 (4) ◽  
pp. 941-945 ◽  
Author(s):  
Philip Kim ◽  
Sumeet Syan-Bhanvadia ◽  
Hooman Djaladat ◽  
Ken Faber ◽  
Nicholas N. Tadros ◽  
...  

Cancer ◽  
2006 ◽  
Vol 107 (7) ◽  
pp. 1503-1510 ◽  
Author(s):  
Philippe E. Spiess ◽  
Gordon A. Brown ◽  
Louis L. Pisters ◽  
Ping Liu ◽  
Shi-Ming Tu ◽  
...  

2007 ◽  
Vol 25 (28) ◽  
pp. 4365-4369 ◽  
Author(s):  
Brett S. Carver ◽  
Bobby Shayegan ◽  
Scott Eggener ◽  
Jason Stasi ◽  
Robert J. Motzer ◽  
...  

Introduction Modified template retroperitoneal lymph node dissections (RPLND) have become increasing applied in the postchemotherapy (PC) setting. We evaluated our experience with PC-RPLND to determine the incidence of disease extending outside the boundaries of a modified PC-RPLND. Patients and Methods From 1989 through 2003, a total of 532 men underwent PC-RPLND for metastatic nonseminomatous germ cell tumor (NSGCT). Of these, 269 (51%) had either viable germ cell tumor (GCT) or teratoma present in the RPLND specimen. After Institutional Review Board approval, clinical and pathologic data were obtained from our prospective surgical database. The incidence of retroperitoneal disease outside the boundaries of five modified templates was reported for the presence of viable GCT or teratoma. Results Of the 269 patients with viable GCT or teratoma, 20 to 86 (7% to 32%) patients had evidence of extratemplate retroperitoneal disease, depending on the boundaries of the modified template. There was no difference in the histologic distribution for patients with disease confined to or outside of the modified templates. Despite the absence of preoperative radiographic evidence of disease outside the boundaries of the Testicular Tumor Study Group template, the incidence of extratemplate metastasis for men with residual retroperitoneal masses less than 1, 1 to 2, 2 to 5, and more than 5 cm was two of 24 (8%), seven of 38 (18%), 27 of 92 (29%), and 14 of 55 (25%), respectively. Conclusion Our data suggest a bilateral RPLND is a prudent approach for the management of men with metastatic NSGCT after chemotherapy, given that at least 7% to 32% of men will have teratoma or viable GCT outside the boundaries of a modified template.


Videourology ◽  
2016 ◽  
Vol 30 (5) ◽  
Author(s):  
Michael T. Marshall ◽  
Jonathan H. Berger ◽  
Haidar M. Abdul-Muhsin ◽  
Sean P. Stroup ◽  
Ithaar H. Derweesh ◽  
...  

Urology ◽  
2009 ◽  
Vol 73 (2) ◽  
pp. 442.e17-442.e19 ◽  
Author(s):  
Yaron Ehrlich ◽  
Daniel Kedar ◽  
Avigdor Zelikovski ◽  
Miriam Konichezky ◽  
Jack Baniel

Sign in / Sign up

Export Citation Format

Share Document